Codexis to Participate in Cantor Global Healthcare Conference 2026
Codexis (NASDAQ: CDXS) will participate in the Cantor Global Healthcare Conference 2026, held September 9-11, 2026, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Codexis (NASDAQ: CDXS) will participate in the Cantor Global Healthcare Conference 2026, held September 9-11, 2026, in New York. Management is scheduled for a fireside chat on Thursday, September 10, 2026, at 9:45 a.m. ET, with a live webcast and 90-day replay via Codexis’ investor relations website.
Details
News Market Reaction – CDXS
On Aug 27, the day this news came out, CDXS closed 0.61% above the previous close. Our momentum scanner recorded 3 alerts in the available session data.
Data tracked by StockTitan Argus for the Aug 27 session.
Key Figures
- Conference dates
- September 9-11, 2026
- Cantor Global Healthcare Conference 2026
- Fireside chat
- September 10, 2026 at 9:45 am ET
- Management participation at the conference
- Replay availability
- 90 days
- Webcast replay following the event
Historical Context
-
Narrower loss, improved margin, reiterated guidance, and extended operating cash outlook
-
Added technical and industry expertise to support oligonucleotide manufacturing growth
-
Announced the date and webcast details for second-quarter financial results
-
Priced 16,666,667 shares at $1.50 for approximately $23.1 million net proceeds
-
Proposed company stock offering with potential additional shares and unspecified terms
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
rnai therapeutics medical
nucleic acid synthesis technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference 2026, being held September 9-11, 2026, in New York, New York.
Management will participate in a fireside chat on Thursday, September 10, 2026, at 9:45 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis® is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis® Manufacturing Platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing, and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Georgia Erbez
(650) 421-8100
ir@codexis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.